breast cancer care
breast cancer care Company Information
Company Number
02447182
Next Accounts
Apr 2026
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
6th floor, the white chapel buil, 10 whitechapel high street, london, E1 8QS
breast cancer care Estimated Valuation
Pomanda estimates the enterprise value of BREAST CANCER CARE at £0 based on a Turnover of £0 and 0.53x industry multiple (adjusted for size and gross margin).
breast cancer care Estimated Valuation
Pomanda estimates the enterprise value of BREAST CANCER CARE at £0 based on an EBITDA of £0 and a 4.1x industry multiple (adjusted for size and gross margin).
breast cancer care Estimated Valuation
Pomanda estimates the enterprise value of BREAST CANCER CARE at £0 based on Net Assets of £0 and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Breast Cancer Care Overview
Breast Cancer Care is a live company located in london, E1 8QS with a Companies House number of 02447182. It operates in the other human health activities sector, SIC Code 86900. Founded in November 1989, it's largest shareholder is unknown. Breast Cancer Care is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Breast Cancer Care Health Check
There is insufficient data available to calculate a health check for Breast Cancer Care. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Breast Cancer Care
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Breast Cancer Care
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Breast Cancer Care
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Breast Cancer Care
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Breast Cancer Care
- - Industry AVG
BREAST CANCER CARE financials
Breast Cancer Care's latest turnover from July 2024 is estimated at 0 and the company has net assets of 0. According to their latest financial statements, we estimate that Breast Cancer Care has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 19,544,000 | 16,192,000 | 16,899,000 | 17,036,000 | 16,575,000 | 15,353,000 | 13,359,000 | 12,675,000 | 12,187,000 | 11,093,000 | |||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | 1,088,000 | 429,000 | |||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -8,752,000 | -103,000 | 465,000 | -49,000 | 1,088,000 | 429,000 | 178,000 | -1,000,000 | -1,647,000 | -1,588,000 | |||||
| Tax | |||||||||||||||
| Profit After Tax | -8,752,000 | -103,000 | 465,000 | -49,000 | 1,088,000 | 429,000 | 178,000 | -1,000,000 | -1,647,000 | -1,588,000 | |||||
| Dividends Paid | |||||||||||||||
| Retained Profit | -8,752,000 | -103,000 | 465,000 | -49,000 | 1,088,000 | 429,000 | 178,000 | -1,000,000 | -1,647,000 | -1,588,000 | |||||
| Employee Costs | 7,907,000 | 7,778,000 | 7,961,000 | 8,180,000 | 7,280,000 | 6,899,000 | 6,627,000 | 7,072,000 | 7,098,000 | 6,868,000 | |||||
| Number Of Employees | 203 | 207 | 96 | 230 | 211 | 179 | 165 | 181 | 186 | 183 | |||||
| EBITDA* | 1,237,000 | 848,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 710,000 | 799,000 | 351,000 | 320,000 | 469,000 | 749,000 | 1,080,000 | 1,410,000 | 1,362,000 | ||||||
| Intangible Assets | 113,000 | 110,000 | 138,000 | 124,000 | |||||||||||
| Investments & Other | 3,868,000 | 3,941,000 | 4,639,000 | 4,895,000 | 4,821,000 | 4,115,000 | 4,585,000 | 5,629,000 | 6,180,000 | ||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 4,691,000 | 4,850,000 | 5,128,000 | 5,339,000 | 5,290,000 | 4,864,000 | 5,665,000 | 7,039,000 | 7,542,000 | ||||||
| Stock & work in progress | 64,000 | 88,000 | 121,000 | 72,000 | 20,000 | 12,000 | 12,000 | 24,000 | 22,000 | ||||||
| Trade Debtors | 772,000 | 173,000 | 340,000 | 109,000 | 510,000 | 461,000 | 406,000 | 406,000 | 700,000 | ||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 2,708,000 | 2,146,000 | 2,726,000 | 2,241,000 | 1,605,000 | 1,623,000 | 1,175,000 | 892,000 | 1,125,000 | ||||||
| Cash | 1,867,000 | 2,747,000 | 1,664,000 | 2,156,000 | 1,824,000 | 707,000 | 390,000 | 161,000 | 93,000 | ||||||
| misc current assets | 11,000 | 510,000 | 518,000 | 509,000 | 500,000 | 1,000,000 | 1,000,000 | 1,277,000 | 1,915,000 | ||||||
| total current assets | 5,422,000 | 5,664,000 | 5,369,000 | 5,087,000 | 4,459,000 | 3,803,000 | 2,983,000 | 2,760,000 | 3,855,000 | ||||||
| total assets | 10,113,000 | 10,514,000 | 10,497,000 | 10,426,000 | 9,749,000 | 8,667,000 | 8,648,000 | 9,799,000 | 11,397,000 | ||||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 121,000 | 174,000 | 173,000 | 98,000 | 234,000 | 37,000 | |||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 961,000 | 1,270,000 | 1,373,000 | 1,036,000 | 1,506,000 | 1,400,000 | 1,782,000 | 1,936,000 | 2,113,000 | ||||||
| total current liabilities | 1,082,000 | 1,444,000 | 1,546,000 | 1,134,000 | 1,740,000 | 1,437,000 | 1,782,000 | 1,936,000 | 2,113,000 | ||||||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | 810,000 | 358,000 | 310,000 | 249,000 | 304,000 | ||||||||||
| other liabilities | 324,000 | 198,000 | 155,000 | 208,000 | 261,000 | 235,000 | 200,000 | 69,000 | |||||||
| provisions | 260,000 | 251,000 | 1,107,000 | 987,000 | |||||||||||
| total long term liabilities | 584,000 | 449,000 | 1,107,000 | 1,142,000 | 1,018,000 | 619,000 | 545,000 | 449,000 | 373,000 | ||||||
| total liabilities | 1,666,000 | 1,893,000 | 2,653,000 | 2,276,000 | 2,758,000 | 2,056,000 | 2,327,000 | 2,385,000 | 2,486,000 | ||||||
| net assets | 8,447,000 | 8,621,000 | 7,844,000 | 8,150,000 | 6,991,000 | 6,611,000 | 6,321,000 | 7,414,000 | 8,911,000 | ||||||
| total shareholders funds | 8,447,000 | 8,621,000 | 7,844,000 | 8,150,000 | 6,991,000 | 6,611,000 | 6,321,000 | 7,414,000 | 8,911,000 |
| Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 1,088,000 | 429,000 | |||||||||||||
| Depreciation | 154,000 | 307,000 | 227,000 | 133,000 | 149,000 | 419,000 | 395,000 | 459,000 | 350,000 | 378,000 | |||||
| Amortisation | 58,000 | 58,000 | 48,000 | ||||||||||||
| Tax | |||||||||||||||
| Stock | -64,000 | -24,000 | -33,000 | 49,000 | 52,000 | 8,000 | -12,000 | 2,000 | 22,000 | ||||||
| Debtors | -3,480,000 | 1,161,000 | -747,000 | 716,000 | 235,000 | 31,000 | 503,000 | 283,000 | -527,000 | 1,825,000 | |||||
| Creditors | -121,000 | -53,000 | 1,000 | 75,000 | -136,000 | 197,000 | 37,000 | ||||||||
| Accruals and Deferred Income | -961,000 | -309,000 | -103,000 | 337,000 | -1,280,000 | 558,000 | -334,000 | -93,000 | -232,000 | 2,417,000 | |||||
| Deferred Taxes & Provisions | -260,000 | 9,000 | -856,000 | 120,000 | 987,000 | ||||||||||
| Cash flow from operations | 521,000 | 1,564,000 | |||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -156,000 | -219,000 | 364,000 | -219,000 | -128,000 | -894,000 | 518,000 | 822,000 | 303,000 | 518,000 | |||||
| Change in Investments | -3,868,000 | -73,000 | -698,000 | -256,000 | 74,000 | 706,000 | -470,000 | -1,044,000 | -551,000 | 6,180,000 | |||||
| cash flow from investments | 3,712,000 | -146,000 | 1,062,000 | 37,000 | -202,000 | -1,600,000 | 988,000 | 1,866,000 | 854,000 | -5,662,000 | |||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | -324,000 | 126,000 | 198,000 | -155,000 | -53,000 | -53,000 | 26,000 | 35,000 | 131,000 | 69,000 | |||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | -19,000 | 55,000 | 510,000 | -412,000 | 18,000 | -102,000 | 138,000 | -58,000 | 281,000 | 10,568,000 | |||||
| cash and cash equivalents | |||||||||||||||
| cash | -1,867,000 | -880,000 | 1,083,000 | -492,000 | 332,000 | 1,117,000 | 317,000 | 229,000 | 68,000 | 93,000 | |||||
| overdraft | |||||||||||||||
| change in cash | -1,867,000 | -880,000 | 1,083,000 | -492,000 | 332,000 | 1,117,000 | 317,000 | 229,000 | 68,000 | 93,000 |
breast cancer care Credit Report and Business Information
Breast Cancer Care Competitor Analysis
Perform a competitor analysis for breast cancer care by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mature companies, companies in E 1 area or any other competitors across 12 key performance metrics.
breast cancer care Ownership
BREAST CANCER CARE group structure
Breast Cancer Care has no subsidiary companies.
Ultimate parent company
BREAST CANCER CARE
02447182
breast cancer care directors
Breast Cancer Care currently has 4 directors. The longest serving directors include Mrs Jill Thompson (Dec 2016) and Mr Chay Champness (Nov 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Jill Thompson | England | 60 years | Dec 2016 | - | Director |
| Mr Chay Champness | 53 years | Nov 2020 | - | Director | |
| Mrs Claire Rowney | England | 52 years | Sep 2024 | - | Director |
| Mr Keith Felton | 66 years | Sep 2024 | - | Director |
P&L
July 2024turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2024net assets
0
0%
total assets
0
0%
cash
0
0%
net assets
Total assets minus all liabilities
breast cancer care company details
company number
02447182
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
November 1989
age
36
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
July 2024
previous names
breast care & mastectomy association of great britain (February 1994)
accountant
-
auditor
-
address
6th floor, the white chapel buil, 10 whitechapel high street, london, E1 8QS
Bank
HSBC BANK PLC
Legal Advisor
-
breast cancer care Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to breast cancer care.
breast cancer care Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BREAST CANCER CARE. This can take several minutes, an email will notify you when this has completed.
breast cancer care Companies House Filings - See Documents
| date | description | view/download |
|---|
